Svenja Bütschi

Svenja Bolz is a Medical Advisor at Ethypharm, specializing in CNS and cardiology, with responsibilities including medical advisory, compliance, training, and relationship management since July 2024. Prior to this role, Svenja served as a Postdoctoral Researcher and Associate Researcher at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie from July 2018 to June 2024, focusing on hippocampal preservation and regeneration through advanced microscopy and molecular biology techniques. Svenja's research experience includes positions as a Research Assistant at the University of Melbourne, analyzing neurodegenerative diseases, and at other esteemed institutions such as the Max Delbrück Center and Washington University in St. Louis, contributing to studies on synaptic proteins and protein misfolding. Svenja holds a Doctor of Science from Freie Universität Berlin, a Master of Science in Biochemistry and Molecular Biology from the University of Potsdam, and a Bachelor of Science in Biochemistry from the same institution.